Professor Gunnar Saeter has been appointed head of the Institute for Cancer Research Oslo University Hospital where he leads the basic and translational cancer research at the Comprehensive Cancer Center. His previous position was Global Director of Scientific Affairs for Merck (MSD) Oncology, where his main responsibilities included external scientific input, collaborations with world wide cancer academia, and the chairmanship of the Merck Investigator Initiated Study Program for oncology.
Gunnar Sæter was formally appointed August 1st 2013, taking over from Erik Boye, who served as acting head after Øystein Fodstad.
Brief résumé of professor Gunnar Sæter's scientific background:
Dr. Sæter earned his M.D. from The Royal College of Surgeons in Ireland in 1979, became board specified specialist in medical oncology and radiation oncology in 1990 and Associate Professor of Oncology at the University of Oslo in 2004. He obtained his Ph.D. degree in 1989: "Cell Proliferation and Tumour Promotion in Experimental and Human Liver Carcinogenesis" (University of Oslo). He has held senior positions including Head of Medical Oncology at The Norwegian Radium Hospital, Oslo (2000-2006), and General Chief Physician at Ulleval University Hospital in Oslo (2006-2009).
Dr. Sæter's has broad experience in clinical oncology, cancer research and hospital administration, both at a national and international level. He has participated and chaired multiple governmental bodies and advisory committees on cancer care, cancer research and health care organization. His particular interest has been bone and soft tissue sarcomas, with a key role as Secretary and Clinical Research Coordinator in the Scandinavian Sarcoma Group (SSG). This position included PI functions for intergroup clinical studies conducted by SSG and The Italian Sarcoma Group (ISG). His list of publications holds in excess of 200 titles.
Gunnar Sæter's CV, including publications